DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09
NexLife T $215✓Yucca Health T $258✓IVIM Health T $278✓Mochi Health T $278✓ShedRx T $289✓Found T $289✓SkinnyRx T $299✓OrderlyMeds T $299✓Amble Health T $300✓Henry Meds T $349✓TrimRx T $349✓Lavender Sky Health T $352✓Fridays T $359✓MEDVi T $399✓Remedy Meds T $399✓Eden T $408✓LifeMD T $597✓Oak Longevity S $133✓Yucca Health S $146✓IVIM Health S $149✓OrderlyMeds S $149✓NexLife S $165✓Lavender Sky Health S $174✓Zepbound vials $449✓Wegovy $349✓Oral Wegovy from $149✓NexLife T $215✓Yucca Health T $258✓IVIM Health T $278✓Mochi Health T $278✓ShedRx T $289✓Found T $289✓SkinnyRx T $299✓OrderlyMeds T $299✓Amble Health T $300✓Henry Meds T $349✓TrimRx T $349✓Lavender Sky Health T $352✓Fridays T $359✓MEDVi T $399✓Remedy Meds T $399✓Eden T $408✓LifeMD T $597✓Oak Longevity S $133✓Yucca Health S $146✓IVIM Health S $149✓OrderlyMeds S $149✓NexLife S $165✓Lavender Sky Health S $174✓Zepbound vials $449✓Wegovy $349✓Oral Wegovy from $149✓

2026-08-10 · TIRZEPATIDE · TopGLP1Providers Data Desk

Microdosed tirzepatide: the price is real, the evidence is not there yet

"Microdosing" tirzepatide — staying at or below the 2.5 mg starter dose, or stretching intervals beyond weekly — has become a priced product tier: NexLife↗ sells a microdose tirzepatide protocol at $189 a month (stepping to $147 on a prepaid year), about $26 under its standard program. The commercial logic is straightforward: less drug, lower price. The clinical logic is unproven — no randomized trial supports sub-therapeutic tirzepatide dosing for weight management, and the SURMOUNT program that established tirzepatide's results used the standard ladder.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

Why do people want it anyway? Three honest reasons show up repeatedly: side-effect sensitivity at standard doses, maintenance after reaching a goal weight, and budget. The first two are real clinical conversations — some prescribers do hold patients at low doses deliberately, and dose individualization is ordinary medicine. What the marketing adds, and the evidence does not, is the suggestion that a fraction of the studied dose reliably delivers a meaningful fraction of the studied result. Appetite effects at 2.5 mg exist — that is why titration starts there — but the trial data treats 2.5 mg as a tolerability on-ramp, not a destination, and nobody has published outcomes for staying there indefinitely.

The pricing angle this site can actually verify: microdose tiers are among the cheapest ways a program can put "tirzepatide" and a low number in the same sentence, so treat them as a separate product when comparing. Our rankings never mix microdose prices into the standard-protocol index — NexLife's $189 microdose figure is listed on its provider page as its own line, not blended into the $215 standard figure, and the same separation applies to the semaglutide microdose tier at $129. If a program you are considering quotes one number and only later reveals it was the microdose tier, that is a pricing-honesty failure, and the vetting checklist applies. If your interest is clinical — tapering, maintenance, tolerability — take the question to the prescriber, not the pricing page.

Not medical advice, and not an endorsement of sub-therapeutic dosing; discuss any dosing strategy with a licensed clinician.

The cheapest compounded tirzepatide online rigThe cheapest compounded semaglutide online, inCompounded tirzepatide vs ZepboundWhat a year of tirzepatide actually costs, proDose-flat vs dose-tiered pricing